FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier

Citation
I. Bechmann et al., FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier, GLIA, 27(1), 1999, pp. 62-74
Citations number
42
Categorie Soggetti
Neurosciences & Behavoir
Journal title
GLIA
ISSN journal
08941491 → ACNP
Volume
27
Issue
1
Year of publication
1999
Pages
62 - 74
Database
ISI
SICI code
0894-1491(199907)27:1<62:F(AIEI>2.0.ZU;2-D
Abstract
Despite the mechanical blood-brain barrier, activated T-cells can cross bra in vessels. Thus, the CNS is routinely surveyed by immune competent cells; yet the healthy brain is not a target of antigen-specific immune reactions. Therefore, mechanisms must exist to prevent brain-antigen-specific T-cells from inducing immune responses. Data indicate that activated T-cells enter ing the CNS may undergo apoptosis rather than leaving the brain to induce i mmune responses. Applying RT-PCR, Western-blots, and immunocytochemistry, w e have demonstrated expression of the apoptosis-inducing protein Fas ligand on astrocytes and neurons of apparently normal rat and human brains. Fast- positive astrocytes were often situated in close vicinity to cerebral blood vessels in vivo and induced apoptosis of Fas expressing Jurkat cells in vi tro. We propose that similar to other immune privileged organs Fast-induced apoptosis of activated T-cells in the brain protects the tissue from self damaging immune attacks by forming an immunological brain barrier. (C) 1999 Wiley-Liss, Inc.